Home › Trials › NCT05297734

Comparing two supportive care models for adults with cancer

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Not applicable Interventional Stanford University · NCT05297734

This study tests whether adults with cancer feel better and more satisfied with their care when they use technology for support or when they talk with a health worker about their care.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment2996 (estimated)
Ages18 Years and up
SexAll
SponsorStanford University Academic / other
Locations17 sites (Birmingham, Alabama and 16 other locations)
Trial IDNCT05297734 on ClinicalTrials.gov

What this trial studies

This trial compares two different supportive cancer care delivery models for adults with cancer: a technology-based approach and a redesigned team-based approach. Participants are randomly assigned to either receive educational materials through technology or engage with a lay health worker for discussions about the same materials. The study aims to assess the impact of these interventions on health-related quality of life, patient activation, satisfaction with care, and documentation of care goals. Participants will complete surveys at multiple time points to evaluate these outcomes.

Who should consider this trial

Good fit: Ideal candidates include newly diagnosed patients with solid tumor cancers who can provide consent and communicate in English, Spanish, Chinese, or Vietnamese.

Not a fit: Patients who are unable to consent, plan to change oncologists, or anticipate moving within 12 months may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the quality of life and care satisfaction for cancer patients.

How similar studies have performed: Other studies have shown promise in using supportive care models, but this specific comparative approach is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
2. Patients must have the ability to understand and willingness to provide verbal consent.
3. Participants must speak English, Spanish, Chinese, or Vietnamese.

Exclusion Criteria:

1. Inability to consent to the study
2. Plans to change oncologist within 12 months
3. Employed by the practice site
4. Patients who anticipate moving from the area within 12 months

Where this trial is running

Birmingham, Alabama and 16 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions End of LifeCancerCarcinomaLung NeoplasmsCarcinoma, Non-Small-Cell LungMelanomaPancreatic NeoplasmsSarcoma
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.